The pathophysiologic role of alpha 4 integrins in vivo.
Lobb
R R
RR
Biogen, Inc., Cambridge, Massachusetts 02142.
Hemler
M E
ME
D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use; D015815:Cell Adhesion Molecules / Q000032:analysis; D000939:Epitopes; D006412:Hematopoietic Stem Cells / Q000502:physiology; D006801:Humans; D039441:Integrin alpha4; D039041:Integrin alpha4beta1; D016023:Integrins / Q000032:analysis / Q000276:immunology / Q000502:physiology*; D016029:Receptors, Very Late Antigen / Q000032:analysis / Q000276:immunology / Q000502:physiology*; D019010:Vascular Cell Adhesion Molecule-1
D000911:Antibodies, Monoclonal; D015815:Cell Adhesion Molecules; D000939:Epitopes; D039041:Integrin alpha4beta1; D016023:Integrins; D016029:Receptors, Very Late Antigen; D019010:Vascular Cell Adhesion Molecule-1; D039441:Integrin alpha4